UPDATED May 12, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GOOGL | US$168.65 | 0.3% | 44.8% | US$2.1t | US$191.48 | PE25.3x | E12.2% | 0.5% | Media | ||
AMZN | US$187.48 | -0.6% | 68.6% | US$2.0t | US$217.51 | PE51.8x | E21.5% | n/a | Retail | ||
2330 | NT$818.00 | 4.1% | 65.1% | NT$20.8t | NT$919.13 | PE24.8x | E16.3% | 1.7% | Semiconductors | ||
JPM | US$198.77 | 3.5% | 47.0% | US$570.8b | US$207.83 | PB1.9x | E-1.3% | 2.3% | Banks | ||
NOVO B | kr.883.20 | 3.8% | 50.3% | kr.3.9t | kr.908.65 | PE44.1x | E13.3% | 1.1% | Pharmaceuticals & Biotech | ||
WMT | US$60.48 | 1.0% | 19.5% | US$487.5b | US$65.42 | PE31.4x | E10.6% | 1.4% | Consumer Retailing | ||
JNJ | US$149.91 | 0.9% | -6.0% | US$360.8b | US$173.26 | PE21.1x | E6.9% | 3.3% | Pharmaceuticals & Biotech | ||
COST | US$787.19 | 4.1% | 56.8% | US$349.1b | US$778.23 | PE51.4x | E7.5% | 0.6% | Consumer Retailing | ||
CVX | US$165.82 | 2.2% | 5.5% | US$305.6b | US$183.81 | PE15.1x | E2.5% | 3.9% | Energy | ||
600519 | CN¥1,738.98 | 2.0% | 1.9% | CN¥2.2t | CN¥2,161.67 | PE28x | E12.7% | 2.9% | Food, Beverage & Tobacco | ||
NESN | CHF95.18 | 4.2% | -17.1% | CHF249.5b | CHF108.37 | PE22.3x | E7.1% | 3.2% | Food, Beverage & Tobacco | ||
KO | US$63.26 | 1.5% | -1.1% | US$272.5b | US$67.09 | PE25.3x | E7.7% | 3.1% | Food, Beverage & Tobacco | ||
CRM | US$276.67 | 0.4% | 36.1% | US$268.4b | US$337.07 | PE64.9x | E18.6% | 0.6% | Software | ||
PEP | US$179.79 | 2.3% | -7.5% | US$247.2b | US$187.17 | PE26.9x | E9.4% | 3.0% | Food, Beverage & Tobacco | ||
857 | HK$7.68 | 8.0% | 43.0% | HK$1.9t | HK$7.54 | PE8x | E-6.0% | 6.2% | Energy | ||
AZN | UK£123.70 | 2.7% | 3.1% | UK£191.8b | UK£133.20 | PE37.9x | E15.9% | 2.0% | Pharmaceuticals & Biotech | ||
SAP | €176.06 | 2.7% | 46.3% | €204.3b | €186.58 | PE79.3x | E33.2% | 1.2% | Software | ||
WFC | US$61.89 | 2.8% | 59.6% | US$215.8b | US$63.35 | PB1.3x | E3.5% | 2.3% | Banks | ||
GE | US$163.38 | -2.7% | 60.2% | US$178.8b | US$180.69 | PE42.7x | E14.2% | 0.7% | Capital Goods | ||
INTU | US$632.31 | -0.4% | 48.4% | US$177.0b | US$692.58 | PE63.9x | E17.5% | 0.6% | Software | ||
CAT | US$354.79 | 3.7% | 67.9% | US$173.5b | US$340.98 | PE15.4x | E-2.2% | 1.5% | Capital Goods | ||
AMGN | US$310.15 | 3.6% | 32.8% | US$166.4b | US$314.65 | PE44.2x | E17.9% | 2.9% | Pharmaceuticals & Biotech | ||
SIE | €188.40 | 5.0% | 25.1% | €147.7b | €190.83 | PE16.7x | E3.8% | 2.5% | Capital Goods | ||
PM | US$99.66 | 2.3% | 4.9% | US$154.9b | US$109.42 | PE19.5x | E10.0% | 5.2% | Food, Beverage & Tobacco |